trial · primary record
Crovalimab
Paroxysmal Nocturnal Hemoglobinuria
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 210 |
| Primary completion | 2027-04-18 |
| Primary endpoint | Percentage of Participants With Transfusion Avoidance (TA) |
| Registry ID | NCT04434092 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:09.558Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04434092
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.